General Dynamics Armament and Technical Products has won a US$43m contract modification to produce and test Joint Biological Point Detection Systems (JBPDS).
The award by the US Army Research Development and Engineering Command Acquisition Centre is a modification of a 2004 contract, and brings the total value of that contract to US$200m.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
JBPDS is a self-contained instrument suite that rapidly detects and identifies biological warfare agents.
General Dynamics says it is available in man-potable, shelter-based, ship-based and trailer-mounted variants.
By staff writer
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
